{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:55:34Z","timestamp":1790060134084,"version":"4.0.1"},"reference-count":32,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":3964,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1995,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Objective.<\/jats:italic>\n                    To examine the usefulness of determining extended serum cytokine profiles in patients with juvenile rheumatoid arthritis (JRA), for the purpose of improving differential diagnosis and monitoring disease activity.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Methods.<\/jats:italic>\n                    In a 2\u2010year prospective study, serum levels of interleukin\u20101\u03b2 (IL\u20101\u03b2), soluble IL\u20102 receptor (sIL\u20102R), IL\u20106, IL\u20108, tumor necrosis factor \u03b1 (TNF\u03b1), and the p55 soluble TNF receptor (sTNFR) were repeatedly determined by enzyme\u2010linked immunosorbent assay in 40 patients with JRA, 13 patients with postinfectious arthropathies, and 30 healthy controls. The data were compared with conventional parameters of inflammation, such as C\u2010reactive protein (CRP), iron and hemoglobin levels, erythrocyte sedimentation rate (ESR), white blood cell (WBC) counts, and platelet counts. WBC subsets were analyzed by flow cytofluorometry.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Results.<\/jats:italic>\n                    At the first visit and at the peak of inflammatory activity according to CRP levels and\/or ESR, serum levels of sIL\u20102R, IL\u20106, and sTNFR in JRA patients correlated significantly with conventional inflammation indicators, whereas IL\u20101\u03b2, IL\u20108, and TNF\u03b1 did not. No changes in leukocyte subset distribution were noted. Among the different clinical subtypes of JRA, sIL\u20102R, IL\u20106, and sTNFR values at the time of the initial visit showed a pattern similar to CRP, whereby patients with systemic disease exhibited by far the highest values. TNF\u03b1 and IL\u20101\u03b2 were variably elevated in certain JRA subtypes. Patients with postinfectious arthropathies showed elevated levels of CRP, sIL\u20102R, TNF\u03b1, and sTNFR, which did not differ significantly from levels in the various JRA subtypes with the exception of systemic disease. Detailed analysis of types I and II pauciarticular JRA revealed that levels of CRP, IL\u20101\u03b2, and TNF\u03b1 were elevated in patients with type I disease. While these parameters were invariably normal in patients with type II disease, sTNFR and sIL\u20102R were still found to be significantly elevated. Followup studies suggested that persistently high sTNFR values are a better indicator of JRA activity than are measurements of other cytokines or CRP.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion.<\/jats:italic>\n                    JRA is associated with significant and consistent changes in serum levels of inflammatory cytokines and soluble receptors. For the clinical monitoring of JRA, determination of levels of sTNFR, and to some extent sIL\u20102R, may be particularly useful, since these determinations yield information about subtype and\/or activity of disease that is not available from conventional parameters of inflammation.\n                  <\/jats:p>","DOI":"10.1002\/art.1780380209","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T20:40:10Z","timestamp":1171485610000},"page":"211-220","source":"Crossref","is-referenced-by-count":147,"title":["Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes"],"prefix":"10.1002","volume":"38","author":[{"given":"Harald","family":"Mangge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Kenzian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Gallistl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Neuwirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Liebmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Kaulfersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Beaufort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Muntean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Schauenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,12,9]]},"reference":[{"issue":"1","key":"e_1_2_1_2_2","first-page":"15","article-title":"Cytokines and anti\u2010cytokines","volume":"32","author":"Duff GW","year":"1993","journal-title":"Br J Rheumatol"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02207957"},{"key":"e_1_2_1_4_2","first-page":"524","article-title":"Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis","volume":"19","author":"Wolf RE","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_1_5_2","first-page":"239","article-title":"Serum IL\u20102 level in rheumatoid arthritis: correlation with joint destruction and disease progression","volume":"2","author":"Tebib JG","year":"1991","journal-title":"Eur Cytokine Netw"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853899109148051"},{"key":"e_1_2_1_7_2","first-page":"233","article-title":"Interleukin\u20106, soluble interleukin\u20102 receptor and microheterogeneity of alpha\u2010acid glycoprotein: new markers of the acute\u2010phase reaction","volume":"122","author":"Karrer U","year":"1992","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/31.11.725"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780351008"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360409"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310816"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310614"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0952-7915(92)90057-L"},{"key":"e_1_2_1_14_2","first-page":"895","article-title":"Soluble interleukin\u20102 receptor is unhelpful in chronic inflammatory rheumatism","volume":"40","author":"Wendling D","year":"1992","journal-title":"Pathol Biol (Paris)"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360209"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.51.6.731"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/08820139209069371"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000236200"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360408"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00274936"},{"issue":"2","key":"e_1_2_1_21_2","first-page":"195","article-title":"Current proposed revision of JRA criteria","volume":"20","author":"Brewer EJ","year":"1977","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2-6-163"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.69.5.547"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/32.7.589"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(87)91854-X"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009749209095082"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00290260"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780340912"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.08.040190.001345"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(94)90159-7"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0889-857X(21)00131-9","article-title":"Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis","volume":"17","author":"Lipnick RN","year":"1991","journal-title":"Rheum Dis Clin North Am"},{"key":"e_1_2_1_32_2","first-page":"505","article-title":"Multiple inhibitors of mitogen\u2010induced proliferation of normal lymphocytes in juvenile chronic arthritis sera","volume":"8","author":"De Benedetti F","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_33_2","first-page":"1547","article-title":"Immunoregulatory defects in juvenile rheumatoid arthritis: comparison between patients with the systemic or polyarticular forms","volume":"15","author":"Alarcon\u2010Riquelme ME","year":"1988","journal-title":"J Rheumatol"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780380209","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780380209","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T05:54:11Z","timestamp":1696139651000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780380209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,2]]}},"alternative-id":["10.1002\/art.1780380209"],"URL":"https:\/\/doi.org\/10.1002\/art.1780380209","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,2]]}}}